Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anderson Development Company (ADC), a wholly-owned subsidiary of Mitsui Chemicals, is a specialty chemical manufacturer that provides critical materials and services to the life sciences and pharmaceutical industries. The company specializes in the production of high-purity specialty acrylics, polyurethanes, and advanced materials used as intermediates in drug synthesis and medical device manufacturing. ADC operates a significant manufacturing facility in Adrian, Michigan, where it offers contract manufacturing (CMO) services for complex chemical processes. Their expertise includes the development of materials for chromatography, specialty coatings for medical applications, and custom synthesis for pharmaceutical partners. By leveraging the global resources of Mitsui Chemicals, ADC supports the scale-up and commercial production of specialty chemicals required for modern healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anderson Company.